• Pure Extracts (PULL) has signed a tolling agreement for 500 kg of CBD-rich hemp
  • Subsidiary Pure Extracts Manufacturing will extract 80-85 per cent pure CBD distillate from the biomass
  • The biomass has a CBD potency of just over 10 per cent
  • CBD distillate can be used for vape cartridges, topicals, beverages, gummies and chocolates
  • Pure Extracts is a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelics sector
  • Pure Extracts (PULL) is up by 14.71 per cent and is currently trading at C$0.39 per share

Pure Extracts (PULL) has signed a tolling agreement for 500 kg of CBD-rich hemp.

The company’s wholly-owned subsidiary, Pure Extracts Manufacturing, will extract 80-85 per cent pure CBD distillate from the biomass.

With its specific particulate mill size, the biomass runs very efficiently on the company’s Vitalis R200 sub/super-critical CO2 extraction system.

The biomass was sourced from one of Pure Extracts’ preferred suppliers and has a CBD potency of just over 10 per cent.

CBD distillate can be used for vape cartridges, topicals, beverages, gummies and chocolates.

Ben Nikolaevsky, Pure Extracts’ CEO, remarked,

“We are pleased to have entered into this tolling agreement and to have taken delivery of the first 500 kg of milled hemp biomass. We are very familiar with this particular biomass having used it before in the manufacturing of our in-house, branded products, so we know it extracts very well.”

Pure Extracts is a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelics sector.

Pure Extracts (PULL) is up by 14.71 per cent and is currently trading at C$0.39 per share as of 1:39 pm ET.

More From The Market Online

The Market Online’s Weekly Cannabis Report – April 19, 2024

Cannabis news this week: Canopy Growth shareholders overwhelmingly voted to approve a new class of exchangeable shares.

Buzz on the Bullboards: Challenges amid inflation and geopolitical tensions

Canadian and U.S. stock markets grapple with a host of challenges, from surging inflation data to escalating tensions in the Middle East.

Xebra Brands receives second CBD approval by Mexican authority

Xebra Brands (CSE:XBRA) announces it has received its second COFEPRIS approval for CBD product authorization in Mexico.
Canopy Growth - CEO, David Klein.

Canopy Growth shareholders approve Canopy USA asset strategy

After rearranging its capital structure, Canopy Growth (TSX:WEED) will be closer to establishing a U.S.-based multi-state operator.